Get the Stockscreener App
10.33
0.86%
-0.09
Cadrenal Therapeutics Inc stock is traded at $10.33, with a volume of 5,251.
It is down -0.86% in the last 24 hours and down -11.48% over the past month.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
See More
Previous Close:
$10.42
Open:
$10.17
24h Volume:
5,251
Relative Volume:
0.20
Market Cap:
$20.32M
Revenue:
-
Net Income/Loss:
$-4.85M
P/E Ratio:
-33.32
EPS:
-0.31
Net Cash Flow:
$-3.95M
1W Performance:
-10.10%
1M Performance:
-11.48%
6M Performance:
-47.75%
1Y Performance:
+60.53%
1-Day Range:
$10.17
$10.36
1-Week Range:
$10.07
$11.88
52-Week Range:
$5.70
$22.90
Cadrenal Therapeutics Inc Stock (CVKD) Company Profile
Name
Cadrenal Therapeutics Inc
Sector
Industry
Phone
904-300-0701
Address
822 A1A NORTH, PONTE VEDRA
Compare CVKD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVKD
Cadrenal Therapeutics Inc
|
10.33 | 20.49M | 0 | -4.85M | -3.95M | -0.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Cadrenal Therapeutics Inc Stock (CVKD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-23 | Initiated | Noble Capital Markets | Outperform |
Cadrenal Therapeutics Inc Stock (CVKD) Latest News
Using data filters to optimize entry into Cadrenal Therapeutics Inc.Free Swing Trade With Risk Management - Newser
Does 5E Advanced Materials Inc. show high probability of reboundDaily Profit Watch With Forecast Confidence - Newser
Long term hold vs stop loss in Cadrenal Therapeutics Inc.Daily Profit Watch With Forecast Confidence - Newser
Using data models to predict Cadrenal Therapeutics Inc. stock movementROI Focused Watchlist with Trade Confidence - Newser
Exit strategy if you’re trapped in Cadrenal Therapeutics Inc.Free Stable Entry High Return Opportunities - Newser
Volatility clustering patterns for Horizon Space Acquisition I Corp. Equity RightSwing Entry Insight With Forecast Accuracy - Newser
Cadrenal Therapeutics Inc. stock outlook for YEARBuy Strategy with Smart Exit Timing - Newser
Has PTCT formed a bullish divergenceFree Daily Growth Stock Pick Reports - Newser
How Cadrenal Therapeutics Inc. stock performs during market volatilityWeekly Hot Stocks Based on Volume Flow - Newser
What catalysts could drive Cadrenal Therapeutics Inc. stock higher in 2025Beginner Investor Growth Plan For Every Investor - jammulinksnews.com
What are Cadrenal Therapeutics Inc. company’s key revenue driversChart Pattern Growth Plan For Every Investor - jammulinksnews.com
How does Cadrenal Therapeutics Inc. compare to its industry peersEntry Signal Report For Beginners - jammulinksnews.com
Visual analytics tools that track Cadrenal Therapeutics Inc. performanceMonthly Trade Result and Signal Summary - Newser
Is it the right time to buy Cadrenal Therapeutics Inc. stockSwing Trade Insights Backed By Experts - jammulinksnews.com
When is the best time to exit Stratus Properties Inc.Free Real-Time Analysis With Entry Targets - Newser
Why Cadrenal Therapeutics Inc. stock attracts strong analyst attentionFree Alpha Focused Technical Trade Signals - Newser
Using economic indicators to assess Cadrenal Therapeutics Inc. potentialBuy and Hold Return Summary with Charts - Newser
CWT(crosswallet)Free Weekly Potential Breakout Stock List - Newser
Best data tools to analyze Cadrenal Therapeutics Inc. stockAnnual Market Behavior and Sector Summary - Newser
Is Newegg Commerce Inc. stock poised for growthStable Profit Zone and Loss Control Analysis - Newser
Analyzing net buyer seller activity in Cadrenal Therapeutics Inc.Short-Term Growth Watch with Signal Prediction - Newser
Analyzing drawdowns of ORMP with statistical toolsReal-Time AI Sentiment and Price Forecast - Newser
Why did CVKD's EPS remain flat in recent quarters? - AInvest
Should I hold or sell Cadrenal Therapeutics Inc. stock in 2025Maximize gains with proven stock analysis - jammulinksnews.com
Published on: 2025-07-28 18:18:50 - metal.it
Is Cadrenal Therapeutics Inc. stock overvalued or undervaluedExceptional market positioning - jammulinksnews.com
Cadrenal Therapeutics Inc. Stock Performance After Earnings: Historical InsightsInvestment Life Cycle Planning Summary - Newser
Exit strategy if you’re trapped in Cadrenal Therapeutics Inc. Deep Stock Performance and Volatility Analysis - Newser
Using data filters to optimize entry into Cadrenal Therapeutics Inc. Buy and Exit Strategy Based on Momentum - Newser
Analyzing net buyer seller activity in Cadrenal Therapeutics Inc. Free Real Time Trade Opportunity Alerts - Newser
How strong is Cadrenal Therapeutics Inc. company’s balance sheetHigh-yield investments - jammulinksnews.com
Why ONEW stock attracts strong analyst attentionHigh Return Idea With Technical Filter - Newser
Why CARGO Therapeutics Inc. stock attracts strong analyst attentionFree Weekly Watchlist of High Movers - Newser
Published on: 2025-07-27 19:16:14 - jammulinksnews.com
Key External Factors That Drive Playtika Holding Corp. Stock Price MovementsWeekly Big Movers - Newser
Pineapple Company Inc.: Is It Leading or LaggingReal Time Alert Service - Newser
What is the risk reward ratio of investing in Cadrenal Therapeutics Inc. stockGet alerts on the hottest stocks daily - jammulinksnews.com
How volatile is Cadrenal Therapeutics Inc. stock compared to the marketGet professional advice for market timing - jammulinksnews.com
Why EFOI stock attracts strong analyst attentionSmart Money Signals - metal.it
What drives Cadrenal Therapeutics Inc. stock priceJaw-dropping returns - PrintWeekIndia
P 500Consistent high-performance stocks - jammulinksnews.com
Cadrenal Therapeutics Inc. Stock Analysis and ForecastExceptional market performance - Autocar Professional
Is Cadrenal Therapeutics Inc. a good long term investmentHigh-yield market plays - jammulinksnews.com
Outlook Therapeutics Inc. Stock Analysis and ForecastExplosive market performance - jammulinksnews.com
Cadrenal Therapeutics Inc Stock (CVKD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):